AU2003293635A1 - 4'' - modified erythromycin derivatives - Google Patents

4'' - modified erythromycin derivatives

Info

Publication number
AU2003293635A1
AU2003293635A1 AU2003293635A AU2003293635A AU2003293635A1 AU 2003293635 A1 AU2003293635 A1 AU 2003293635A1 AU 2003293635 A AU2003293635 A AU 2003293635A AU 2003293635 A AU2003293635 A AU 2003293635A AU 2003293635 A1 AU2003293635 A1 AU 2003293635A1
Authority
AU
Australia
Prior art keywords
erythromycin derivatives
modified erythromycin
modified
derivatives
erythromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003293635A
Other languages
English (en)
Other versions
AU2003293635A8 (en
Inventor
John Michael Berge
Catherine Simone Victoire Frydrych
Richard Lewis Jarvest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003293635A8 publication Critical patent/AU2003293635A8/xx
Publication of AU2003293635A1 publication Critical patent/AU2003293635A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2003293635A 2002-10-31 2003-10-29 4'' - modified erythromycin derivatives Abandoned AU2003293635A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0225384.7 2002-10-31
GBGB0225384.7A GB0225384D0 (en) 2002-10-31 2002-10-31 Novel compounds
PCT/EP2003/012068 WO2004039822A2 (en) 2002-10-31 2003-10-29 4’’ - modified erythromycin derivatives

Publications (2)

Publication Number Publication Date
AU2003293635A8 AU2003293635A8 (en) 2004-05-25
AU2003293635A1 true AU2003293635A1 (en) 2004-05-25

Family

ID=9946942

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003293635A Abandoned AU2003293635A1 (en) 2002-10-31 2003-10-29 4'' - modified erythromycin derivatives

Country Status (7)

Country Link
US (1) US7351696B2 (https=)
EP (1) EP1558625A2 (https=)
JP (1) JP2006506389A (https=)
AR (1) AR041860A1 (https=)
AU (1) AU2003293635A1 (https=)
GB (1) GB0225384D0 (https=)
WO (1) WO2004039822A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
SI1628989T1 (sl) * 2003-05-13 2007-06-30 Glaxo Group Ltd Nove cikliäśne spojine s 14 in 15 obroäśnimi äśleni
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
BRPI0510328A (pt) * 2004-05-06 2007-10-23 Glaxosmithkline Zagreb macrolìdeos ligados a éster úteis para o tratamento de infecções microbianas
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424959D0 (en) 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424951D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
JP2008540503A (ja) 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用なエーテル結合マクロライド
CN103080121B (zh) 2010-09-20 2015-11-25 瑞士诺华动物保健有限公司 用于制备在二脱氧甲基己糖环的C-4”处被环氧基团修饰的9-脱氧-9a-氮杂-9a-高红霉素A的新方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880009960A (ko) 1987-02-24 1988-10-06 데이빗 로버츠 화학적 화합물
AU3710695A (en) * 1995-04-27 1996-11-18 Laboratorios Aranda, S.A. De C.V. Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
JP2002502366A (ja) * 1996-05-07 2002-01-22 アボット・ラボラトリーズ ３―デスクラジノース―２，３―無水エリスロマイシン誘導体
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
EA200100983A1 (ru) 1999-05-24 2002-10-31 Пфайзер Продактс Инк. Производные 13-метилэритромицина
ES2254389T3 (es) 2000-02-24 2006-06-16 Abbott Laboratories Agentes anti-infecciosos utiles contra cepas bacterianas resistntes a multiples farmacos.
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
JP2006506389A (ja) 2006-02-23
AU2003293635A8 (en) 2004-05-25
US20070037757A1 (en) 2007-02-15
US7351696B2 (en) 2008-04-01
GB0225384D0 (en) 2002-12-11
AR041860A1 (es) 2005-06-01
WO2004039822A2 (en) 2004-05-13
EP1558625A2 (en) 2005-08-03
WO2004039822A3 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2002349676A1 (en) 4-oxoquinoline derivatives
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2001230537A1 (en) Pyridoxazine derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU2003247706A1 (en) 6, 11-4-carbon bridged erythromycin derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU2003293635A1 (en) 4'' - modified erythromycin derivatives
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU2002212263A1 (en) Substituted 5-amino-1-pentene-3-ol derivatives
AU2002221632A1 (en) 5-amino-1-pentene-3-ol substituted derivatives
AU2001289782A1 (en) Pyrrolotriazolopyrimidinone derivatives
AU2001288484A1 (en) Novel metallotexaphyrin derivatives
AU2002358715A1 (en) Tetrahydrobenzfluorene derivatives
AU2003211483A1 (en) 4'-c-cyano-2'-deoxypurine nucleosides
AU2003224149A1 (en) N'-cyano-n-methyl-imidamide derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase